ORLANDO -- Patients with newly diagnosed chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) lived ...

Weve been there, too, and a wellness-inspired gift for the office may help brighten the mood a bit. Whether youre buying for ...

While experts warn that internal alternative provision (IAP) in mainstream schools risks morphing into “costly” pupil ...

Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...

Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...

IRIS Software Group (IRIS), a leading global provider of accounting, HR, payroll, and education software, has launched the ...

Jared Ott made the most of his time at Michigan Tech. The Enterprise team co-president, Pavlis Honors College student and ...

Zanubrutinib and venetoclax combination shows an 87% 36-month PFS rate in CLL/SLL patients, regardless of del (17p)/TP53 or IGHV status. The SEQUOIA trial demonstrates durable minimal residual disease ...

The American Alliance of Orthopaedic Executives (AAOE) has awarded its prestigious Peer Reviewedtm designation to Breg Vision®, reaffirming what many orthopedic practices already know: Breg Vision is ...

In a new trial , the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well ...

XR in Europe will never be the same. UnitedXR Europe opened its doors yesterday, welcoming thousands of attendees and hundreds of speakers from across the XR and spatial computing space. This truly ...

Ahmad, K. , Prien, S. , Penrose, L. and Suh, B. (2026) Successful Application of the Sperm Tail Flexibility Test for Immotile ...